Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial Cystitis/Bladder pain syndrome

Urologia Internationalis

Volumn 92, Issue 2, 2014, Pages 202-208

  Liu, Bo Long ^a   Yang, Fei ^a   Zhan, Hai Lun ^a   Feng, Zhi Ying ^a   Zhang, Zhi Gang ^a   Li, Wen Biao ^a   Zhou, Xiang Fu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Inflammation; Interstitial cystitis; Lower urinary tract symptoms; Nerve growth factor; Transient receptor potential vanilloid receptor subtype 1

Indexed keywords

EOSIN; HEMATOXYLIN; NERVE GROWTH FACTOR; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; CONTROLLED STUDY; CYSTALGIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NERVE FIBER; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUESTIONNAIRE; SCORING SYSTEM; VERY ELDERLY; WESTERN BLOTTING; BIOPSY; BLADDER DISEASE; GENE EXPRESSION REGULATION; METABOLISM; PAIN; PROSPECTIVE STUDY; ASSESSMENT OF HUMANS; CYSTOSCOPY; DENSITY; DISEASE SEVERITY; PELVIC PAIN URGENCY FREQUENCY QUESTIONNAIRE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CYSTITIS, INTERSTITIAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; PAIN; PROSPECTIVE STUDIES; TRPV CATION CHANNELS; URINARY BLADDER DISEASES;

EID: 84900371521     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000355175     Document Type: Article

References (28)

1. Hanno PM, Burks DA, Clemens JQ, et al: AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2011; 185: 2162-2170.
2. Gallego-Vilar D, Garcia-Fadrique G, Povo-Martin I, et al: Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: a prospective, randomized, comparative study. Urol Int 2013; 90: 411-416.
3. Lin XC, Zhang QH, Zhou P, et al: Caveolin-1 may participate in the pathogenesis of bladder pain syndrome/interstitial cystitis. Urol Int 2011; 86: 334-339.
4. Hanno P, Andersson KE, Birder L, et al: Chronic pelvic pain syndrome/bladder pain syndrome: taking stock, looking ahead: ICIRS 2011. Neurourol Urodyn 2012; 31: 375-383.
5. Yiangou Y, Facer P, Dyer NH, et al: Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357: 1337-1339.
6. Caterina MJ, Leffler A, Malmberg AB, et al: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288: 306-313. (Pubitemid 30226186)
7. Mukerji G, Yiangou Y, Agarwal SK, et al: Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 2006; 176: 797-801. (Pubitemid 43927917)
8. Dupont MC, Spitsberegen JM, Kim KB, et al: Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001; 166: 1111-1118. (Pubitemid 32751054)
9. Murray E, Malley SE, Qiao LY, et al : Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder. J Urol 2004; 172: 2434-2439. (Pubitemid 39507549)
10. Amaya F, Oh-hashi K, Naruse Y, et al: Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of dorsal root ganglion neurons. Brain Res 2003; 963: 190-196. (Pubitemid 36126299)
11. Liu HT, Tyagi P, Chancellor MB, et al: Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 2009; 104: 1476-1481.
12. Ochodnicky P, Cruz CD, Yoshimura N, et al: Neurotrophins as regulators of urinary bladder function. Nat Rev Urol 2012; 9: 628-637.
13. Mantyh PW, Koltzenburg M, Mendell LM, et al: Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology 2011; 115: 189-204.
14. Winston J, Toma H, Shenoy M, et al: Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 2001; 89: 181-186. (Pubitemid 32146397)
15. Parsons CL, Dell J, Stanford EJ, et al: Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002; 60: 573-578. (Pubitemid 35246434)
16. Denson MA, Griebling TL, Cohen MB, et al: Comparison of cystoscopic and histological findings in patients with suspected interstitial cystitis. J Urol 2000; 164: 1908-1911.
17. Erickson DR, Tomaszewski JE, Kunselman AR, et al: Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 2008; 179: 1850-1856.
18. Costantini E, Lazzeri M, Pistolesi D, et al: Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril ® ). Urol Int 2013; 91: 81-88.
19. Rossberger J, Fall M, Jonsson O, et al: Longterm results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology 2007; 70: 638-642. (Pubitemid 350030221)
20. Sant GR, Kempuraj D, Marchand JE, et al: The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 2007; 69: 34-40.
21. Keay S, Kleinberg M, Zhang CO, et al: Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 2000; 164: 2112-2118.
22. Gonzalez RR, Fong T, Belmar N, et al: Modulating bladder neuroinflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J Urol 2005; 173: 630-634.
23. Tyagi P, Barclay D, Zamora R, et al: Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 2009; 42: 629-635.
24. Baron R: Capsaicin and nociception: from basic mechanisms to novel drugs. Lancet 2000; 356: 785-786.
25. Premkumar LS, Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408: 985-990. (Pubitemid 32101646)
26. Malone-Lee JG, Al-Buheissi S: Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study. BJU Int 2009; 103: 931-937.
27. Freund MV, Frossard N: The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther 2008; 117: 52-76. (Pubitemid 350192671)
28. Zvara P, Vizzard MA: Exogenous overexpression of NGF in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord. BMC Physiol 2007; 7: 9.